Zepp Health R&D Spending Growth & History (ZEPP)
Zepp Health's r&d spending was $45.3M for fiscal 2025.
View full Zepp Health company overviewZepp Health annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $45.3M | −$841,000 | −1.82% |
| 2024 | 2024-12-31 | $46.2M | −$5.3M | −10.38% |
| 2023 | 2023-12-31 | $51.5M | −$25.8M | −33.37% |
| 2022 | 2022-12-31 | $77.3M | −$3.5M | −4.37% |
| 2021 | 2021-12-31 | $80.8M | −$1.6M | −1.97% |
| 2020 | 2020-12-31 | $82.5M | $20.6M | +33.24% |
| 2019 | 2019-12-31 | $61.9M | $23.6M | +61.64% |
| 2018 | 2018-12-31 | $38.3M | $14.6M | +61.93% |
| 2017 | 2017-12-31 | $23.6M | — | — |
Zepp Health quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.5M | $388,000 | +3.48% |
| Q1 2026 | 2026-03-31 | $13.1M | $757,000 | +6.12% |
| Q4 2025 | 2025-12-31 | $11.0M | — | — |
| Q3 2025 | 2025-09-30 | $10.8M | — | — |
| Q2 2025 | 2025-06-30 | $11.2M | — | — |
| Q1 2025 | 2025-03-31 | $12.4M | — | — |
Zepp Health r&d spending trends
Over the last five fiscal years, Zepp Health's r&d spending decreased from $82.5M to $45.3M, a change of −$37.1M. The latest reported quarter, Q2 2026, shows $11.5M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zepp Health source filings ↗